Tipifarnib

From Wikipedia, the free encyclopedia

You have new messages (last change).
There are very few or no other articles that link to this one.
Please help introduce links in articles on related topics. After links have been created, remove this message.
This article has been tagged since December 2006.

Tipifarnib is a drug that is being investigated in patients 65 years of age and older with newly diagnosed acute myeloid leukemia (AML).

The compound was discovered by and is under investigation by Johnson & Johnson Pharmaceutical Research & Development, L.L.C, with registration number R115777.

[edit] External links


This medical article is a stub. You can help Wikipedia by expanding it.
 This oncology article is a stub. You can help Wikipedia by expanding it.
Retrieved from "http://en.wikipedia.org../../../t/i/p/Tipifarnib.html"